Clinical Professor, Dept of Pediatrics, Stanford Children’s Health
Lucile Packard Children’s Hospital Stanford
PANEL:
Elizabeth D. Mellins, MD, Stanford University
Harumi Jyonouchi, PhD, St. Peter’s University Hospital
Stephen J. Walker, PhD, Wake Forest Institute for Regenerative Medicine
Vice President, Clinical Development Sciences, Axial Therapeutics Inc.
PANEL:
Gabriel Belfort MD, PhD, Axial Therapeutics,
Kevin Sanders MD, Roche/Genentech
Gahan Pandina PhD, Janssen Research and Development
Robert H. Ring PhD, Kaerus Bioscience Ltd.
John Slattery, BioROSA Technologies
Joanna Sambor, MS, VP and Head of Regulatory at MapLight Therapeutics
Co-founder, President & CEO, BioROSA
PANEL:
Manish Arora, BDS, MPH, PhD, Icahn School of Medicine at Mount Sinai
Karen J. Parker, PhD, Stanford University
Robert H. Ring, PhD, Kaerus Bioscience Ltd.
Kevin Sanders, MD, Roche/Genentech
Micheal Paul, PhD, MaraBio Systems Inc.
Neurologist
Phoenix Children’s Hospital and University of Arizona College of Medicine-Phoenix
PANEL:
Samuel Pleasure, MD, PhD, UCSF
James Adams, PhD, Arizona State University,
Manuel Casanova, MD, University of South Carolina
John Gaitanis, MD, Brown University
Jeffrey Lewine, CEO/CSO, Center for Advanced Diagnostics, Evaluation and Therapeutics
Executive Director,
Stiles-Nicholson Brain Institute and Florida Atlantic University College of Medicine
Does a Disrupted, Bidirectional Relationship Between Serotonin and Inflammatory Signaling Support ASD traits? Lessons from Model System Studies
University of Utah
Microglia specific circuit defects in repetitive form of ASD behaviors
University of Washington
Identification of novel drug targets through the analysis of protein interaction network dysfunction
Stark Neurosciences Research Institute, IUSM
Gut microbial metabolites influence the brain and behavior in a preclinical and clinical ASD context
Oregon State University
Multi-omics, microbiome, and behavioral studies show the importance of fatty acids metabolism in Autism Spectrum Disorder
NeurAbilities Healthcare
High Sensitivity for Monogenic Causal Diagnoses in Autism, Including De Novo Variants Representing Novel Disorders, with Trio Whole Genome Sequencing and Data Reanalysis
Cognition Health
Building on research success in Alzheimer’s to make an impact in the field of Autism
Cofounder, The BRAIN Foundation
Changing the Status Quo
CEO, Stalicla
Translating Precision Medicine for Neurodevelopmental Disorders
CMO, Stalicla
Translating Precision Medicine for Neurodevelopmental Disorders
CEO, Jelikalite
Treating Autism with tPBM, New EEG Evidence
CSO, Jelikalite
Treating Autism with tPBM, New EEG Evidence
CEO, Linus Biotechnology Inc.
A Precision Exposome Biomarker Platform for Early Detection and Drug Development in ASD
Director of Science, Precidiag Inc.
Meta-analysis of the autism gut microbiome identifies factors influencing study discrepancies and machine learning classification
Vice Chairman and Senior Advisor at NKGen Biotch
The Regulatory Role of Natural Killer Cells in Neuroinflammation and its Potential Therapeutic Role in ASD
Scientific Advisor, Aprofol
Levoleucovorin Treatment for Autism Spectrum Disorder.
Kickstarting Promising Research Areas: What High Net-Worth Individuals and Family Foundations can do
President & Founder, The BRAIN Foundation
Opening Remarks
Edith J Baerwald Professor and Vice Chairman of the Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai
Harnessing the exposome to diagnose autism
Neurologist
Phoenix Children’s Hospital and University of Arizona College of Medicine-Phoenix
Update on Mitochondrial Research
Director, Psychiatry Service, Shriners Hospital for Children Massachusetts Gen. Hospital, Boston, MA
Evaluation of Transcranial Photobiomodulation in Autism spectrum disorder: Double-blind, placebo-controlled, randomized clinical study of a novel approach
Pediatric Neurologist, Epileptologist, Hasbro Children’s Hospital
Medical Cannabis and Autism
Division Chief, Pediatric Gastroenterology and Nutrition
Director, Center for Celiac Research and Treatment
Director, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children
Evaluation of Zonulin Pathway for personalized treatment of Autism spectrum disorder using a humanized mouse model and human intestinal tissue
Pediatric Gastroenterologist
Private Practice, New York
Professor, Wake Forest Institute for Regenerative Medicine
Wake Forest School of Medicine
Improvement in Gastrointestinal Symptoms, Cognition and Behavior Upon Treatment of ASD- associated Enterocolitis
Professor of Psychiatry, Neuroscience, Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
From rare mutations to common treatments in ASD
Arizona State University
Microbiota Transplant for Pitt Hopkins
Allergy and Immunology, Saint Peter’s University Hospital
Biomarkers of Innate Immune Memory in Autism Spectrum Disorders
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Consultants and The BRAIN Foundation. CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.
CME Consultants designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.